Posted by Michael Wonder on 27 Aug 2019
Pharmacists demand audit over Gliatilin’s insurance benefit
27 August 2019 - A pharmacists’ group demanded an audit against the Ministry of Health and Welfare and the Health Insurance Review and Assessment Service over their granting of insurance benefit to Gliatilin (choline alfoscerate), a drug for cognitive impairment.
Pharmacists said the government was squandering the HIRA’s money because it gave reimbursement to the drug even though its clinical usefulness has not been confirmed.
The Association of Pharmacists for Healthy Society (APHS) on Tuesday requested the Board of Audit and Inspection to look into the health and welfare ministry and HIRA on suspicion of their dereliction of duty concerning the management of reimbursable drugs.
